5 results match your criteria: "Biodefense Center for Infectious and Emerging Diseases[Affiliation]"

The present study aims to better understand the nature of currently circulating GPV strains and their pathological impact on the immune system during natural outbreaks among different duck breeds in Egypt. For this purpose, 99 ducks (25 flocks) of different breeds, aged 14-75 days, were clinically examined, and 75 tissue pools from the thymus, bursa of Fabricius, and spleen were submitted for virus detection and identification. Clinical and postmortem findings were suggestive of GPV infection.

View Article and Find Full Text PDF
Article Synopsis
  • Acinetobacter baumannii is a dangerous pathogen that poses serious infection risks, especially to immunocompromised individuals, and is known for its resistance to most antibiotics.
  • This study analyzed two multidrug-resistant A. baumannii isolates from neonates in a NICU in Egypt, focusing on their antibiotic resistance mechanisms using techniques like whole-genome sequencing and multilocus sequence typing.
  • Both isolates were highly resistant but shared some resistance genes, belonged to the same genetic sequence type (ST931), and exhibited various other genetic elements that contribute to their resistance.
View Article and Find Full Text PDF

Background: High-grade Epithelial Ovarian Cancer (HGEOC) is an aggressive disease that usually presents at an advanced stage. Thus, detecting the circulating cytokines (IFNγ and TNF-α) may serve as a biomarker to identify malignancy and manage therapeutic decisions.

Objectives: Assessing the clinical importance of inflammatory mediators and tumor markers in EOC Egyptian patients compared with benign cases.

View Article and Find Full Text PDF

Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation.

Hum Immunol

July 2024

Faculty of Biotechnology, October University for Modern Sciences and Arts, MSA University, 6 October City 12451, Giza, Egypt. Electronic address:

Breast cancer (BC) continues to be the malignancy with the highest diagnosis rate worldwide. Between 15 % and 30 % of BC patients show overexpressed human epidermal growth factor receptor 2 (HER2), which is linked to poor clinical results in terms of invasiveness and recurrence risk. Passive immunity-based therapeutic approaches for treating HER2-enriched BC, are not effective and significant problems need to be tackled.

View Article and Find Full Text PDF